ATE226836T1 - Knochenzement mit antimikrobiellen peptiden - Google Patents

Knochenzement mit antimikrobiellen peptiden

Info

Publication number
ATE226836T1
ATE226836T1 AT99931589T AT99931589T ATE226836T1 AT E226836 T1 ATE226836 T1 AT E226836T1 AT 99931589 T AT99931589 T AT 99931589T AT 99931589 T AT99931589 T AT 99931589T AT E226836 T1 ATE226836 T1 AT E226836T1
Authority
AT
Austria
Prior art keywords
bone cement
amino acids
amps
bone
domain
Prior art date
Application number
AT99931589T
Other languages
English (en)
Inventor
Elisabeth Henri Tte Burger
Nieuw Amerongen Arie Van
Paulus Ignatius Jozef Wuisman
Original Assignee
Stichting Skeletal Tissue Engi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Skeletal Tissue Engi filed Critical Stichting Skeletal Tissue Engi
Application granted granted Critical
Publication of ATE226836T1 publication Critical patent/ATE226836T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005—The prosthesis being constructed from a particular material
    • A61F2310/00179—Ceramics or ceramic-like structures
    • A61F2310/00293—Ceramics or ceramic-like structures containing a phosphorus-containing compound, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Surgery (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT99931589T 1998-07-02 1999-07-02 Knochenzement mit antimikrobiellen peptiden ATE226836T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98202233 1998-07-02
PCT/NL1999/000417 WO2000001427A1 (en) 1998-07-02 1999-07-02 Bone cement with antimicrobial peptides

Publications (1)

Publication Number Publication Date
ATE226836T1 true ATE226836T1 (de) 2002-11-15

Family

ID=8233884

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99931589T ATE226836T1 (de) 1998-07-02 1999-07-02 Knochenzement mit antimikrobiellen peptiden

Country Status (10)

Country Link
EP (1) EP1091774B1 (de)
JP (1) JP2002519155A (de)
AT (1) ATE226836T1 (de)
AU (1) AU762262B2 (de)
CA (1) CA2336030A1 (de)
DE (1) DE69903732T2 (de)
DK (1) DK1091774T3 (de)
ES (1) ES2186377T3 (de)
PT (1) PT1091774E (de)
WO (1) WO2000001427A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1228772A1 (de) * 2001-02-01 2002-08-07 AM-Pharma B.V. Neuartiger Knochenzement mit bioaktiven Wirkstoffen
US7608258B2 (en) 2002-04-13 2009-10-27 Allan Mishra Method for treatment of tendinosis using platelet rich plasma
US6811777B2 (en) 2002-04-13 2004-11-02 Allan Mishra Compositions and minimally invasive methods for treating incomplete connective tissue repair
WO2005065242A2 (en) 2003-12-29 2005-07-21 Am Biosolutions Method of treating cancer using platelet releasate
US7462268B2 (en) 2004-08-20 2008-12-09 Allan Mishra Particle/cell separation device and compositions
KR101487719B1 (ko) 2006-05-16 2015-01-29 페르가뭄 아베 개선된 항미생물성 펩타이드
US20100112081A1 (en) 2008-10-07 2010-05-06 Bioparadox, Llc Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities
JP2012180302A (ja) * 2011-03-01 2012-09-20 Tokai Univ 抗グラム陰性菌剤
US9556226B2 (en) 2013-03-15 2017-01-31 The Board Of Trustees Of The University Of Arkansas Peptides with antifungal activity and methods of using the peptides
US20140356893A1 (en) 2013-06-04 2014-12-04 Allan Mishra Compositions and methods for using platelet-rich plasma for drug discovery, cell nuclear reprogramming, proliferation or differentiation
CN118787727B (zh) * 2024-08-26 2025-03-11 中国科学院南海海洋研究所 一种清除铜绿假单胞菌的多肽及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294605A (en) * 1990-07-19 1994-03-15 The Scripps Research Institute Amphiphilic peptide compositions and analogues thereof
DE69223844T2 (de) * 1991-04-24 1998-04-16 Morinaga Milk Industry Co Ltd Antimikrobielles Peptid und antimikrobieller Wirkstoff
US5270300A (en) * 1991-09-06 1993-12-14 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
CA2151486A1 (en) * 1993-01-12 1994-07-21 Arthur J. Ammann Tgf-beta formulation for inducing bone growth
US5522893A (en) * 1993-03-12 1996-06-04 American Dental Association Health Foundation Calcium phosphate hydroxyapatite precursor and methods for making and using the same
EP0830149A1 (de) * 1995-06-06 1998-03-25 Osteogenics Inc. Bioverträgliche hydroxyapatitformulierungen und ihre verwendung
US5994306A (en) * 1995-11-22 1999-11-30 Intrabiotics Pharmaceuticals, Inc. Fine-tuned protegrins
NL1008139C2 (nl) * 1998-01-27 1999-07-28 Stichting Tech Wetenschapp Antimicrobiële peptiden.
JPH11310540A (ja) * 1998-04-28 1999-11-09 Nippon Electric Glass Co Ltd 薬物徐放材料

Also Published As

Publication number Publication date
WO2000001427A1 (en) 2000-01-13
AU762262B2 (en) 2003-06-19
EP1091774B1 (de) 2002-10-30
DE69903732T2 (de) 2003-07-03
PT1091774E (pt) 2003-03-31
ES2186377T3 (es) 2003-05-01
DK1091774T3 (da) 2003-02-24
EP1091774A1 (de) 2001-04-18
DE69903732D1 (de) 2002-12-05
AU4804099A (en) 2000-01-24
JP2002519155A (ja) 2002-07-02
CA2336030A1 (en) 2000-01-13

Similar Documents

Publication Publication Date Title
DE69835279D1 (de) Zusammensetzungen und verfahren zur behandlung von infektionen unter verwendung von kationischen peptiden allein oder in kombination mit antibiotika
DE69903732D1 (de) Knochenzement mit antimikrobiellen peptiden
HUP0004381A3 (en) Method for microbial production of amino acids of the aspartate and/or glutamate family and agents which can be used in said method
DE69922819D1 (de) Methode zur prävention und behandlung von dehnungsstreifen (striae distensae) und deren verwendung in dermatologie
ATE347902T1 (de) Methode zur verabreichung von peptiden mit insulinotroper wirkung
GR3019901T3 (en) Osteoinductive pharmaceutical formulations
DE60031030D1 (de) Verfahren zur Identifizierung von Peptiden und Proteinen mittels Massenspektromterie
ZA989014B (en) Process for the microbial production of amino acids of the aspartate and/or glutamate family and means used in the process.
DE69800768D1 (de) Verfahren zur Beendigung des Nachhärtens von Silikonelastomeren mit Aminosäureestern
DE69613063D1 (de) Zusammensetzungen und Verfahren zur Wirkungsverstärkung von Antibiotika mit Polyphenolen
DE69920877D1 (de) Antimikrobiell wirksame peptide
DE59506057D1 (de) Kollagenzubereitung zur gesteuerten abgabe von wirkstoffen
AU8649101A (en) Integrin binding motif containing peptides and methods of treating skeletal diseases
PL302304A1 (en) Peptides of body organs protecting action, method of obtaining them and their application in therapy
DE60006183D1 (de) Härtungsbeschleuniger und Harzzusammensetzung
GB2219997B (en) Heat curing cement composition,method of hardening same,and hardened body formed therefrom
EE200000760A (et) Meditsiinis implataatidena kasutamiseks mõeldud vormitud kehad ja selliste vormitud kehade valmistamismeetod
IL143516A (en) E3 ubiquitin ligase polypeptide, polynucleotide encoding the same and uses thereof
IL133172A0 (en) Diphosphonic acid salts for the treatment of osteoporosis
ATE353859T1 (de) Beschleunigerzusammensetzung zur beschleunigung des erstarrens und/oder erhärtens einer zementzusammensetzung
BR9708712A (pt) Processo para a preparação de uma resina avançada e composição curada
GB9929497D0 (en) Improved amino acid mixtures for the treatment and/or management of certain diseases
DE69736376D1 (de) Material zur tierabfallbehandlung und verfahren zur dessen herstellung
EP1189584A4 (de) Zusammensetzungen von alpha-aminosäuren und methoden für die behandlung der haut
GB2396617B (en) Polymeric materials

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1091774

Country of ref document: EP

REN Ceased due to non-payment of the annual fee